Invesco Ltd. Affimed N.V. Transaction History

Invesco Ltd.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.66 - $1.29 $14,693 - $28,719	22,263 Added 36.94%	82,529 $61,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $5,451 - $12,142	4,956 Added 8.96%	60,266 $74,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $13,896 - $23,538	7,090 Added 14.7%	55,310 $114,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $11,154 - $23,882	4,914 Added 11.35%	48,220 $134,000
Q1 2022 May 16, 2022	BUY	$3.69 - $5.65 $4,579 - $7,011	1,241 Added 2.95%	43,306 $189,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $86,306 - $113,629	-16,072 Reduced 27.65%	42,065 $232,000
Q3 2021 Nov 15, 2021	BUY	$5.54 - $7.51 $66,180 - $89,714	11,946 Added 25.86%	58,137 $360,000
Q2 2021 Aug 17, 2021	BUY	$7.78 - $11.4 $106,554 - $156,134	13,696 Added 42.15%	46,191 $392,000
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $41,943 - $69,468	8,192 Added 33.71%	32,495 $257,000
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $178,201 - $396,442	-56,393 Reduced 69.88%	24,303 $141,000
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $30,692 - $44,532	-9,415 Reduced 10.45%	80,696 $273,000
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $29,072 - $85,192	18,400 Added 25.66%	90,111 $417,000
Q1 2020 May 15, 2020	SELL	$1.44 - $3.02 $30,787 - $64,567	-21,380 Reduced 22.97%	71,711 $114,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $32,220 - $43,962	14,320 Added 18.18%	93,091 $255,000
Q3 2019 Nov 14, 2019	BUY	$2.67 - $3.65 $210,318 - $287,514	78,771 New	78,771 $232,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.